| Tag | Content |
|---|
EnhancerAtlas ID | HS136-10546 |
Organism | Homo sapiens |
Tissue/cell | Monocyte |
Coordinate | chr2:69854850-69856880 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| DUX4 | MA0468.1 | chr2:69856593-69856604 | TAATCCAATCA | + | 6.02 | | RUNX1 | MA0002.2 | chr2:69855512-69855523 | AAACCACAGAA | - | 6.32 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10031 | chr2:69854914-69856591 | CD14 | | SE_18698 | chr2:69854360-69857435 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19570 | chr2:69855137-69856337 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I069628 | chr2 | 69855173 | 69856332 |
|
Enhancer Sequence | TCCTTATGAG ATCTCACTCC ATTTCAGTTT TCATTCCTAT CTTGTGGTTT TATGACAACT 60
CCCACTCCAA CTTTTCTCTA CAATGCAGGC CAGTCCTATG CAACAGCATC CTGAACTACA 120
TCCATACTTG GATTTCCACT GATGGCTCAT TAAAAAGTCC CTAACTGAAG CCCGTCTCTT 180
TTCCTCAAAC ACTATTCTTT CTTCTTTTTA TTGACACCAT TATCTACCCA GTCACTTAAG 240
CCAGTAGCCC AAGATCCAAT CTAGCTTTCT GTCATCTGCA ACATCTAATT ATTAACACTG 300
ATTTTTCTAA GTTTAAGGTA AAGATATAGA AAGAAGGAAA GCAGAAAAAA AGGAATGGAA 360
TCTTTCACCT CCAGTAAGAA TGATACCTCC CTGTGAGGAC CATACGTAGG CCAAGGTTAA 420
CAATCCACCT CAAAACTATT GTCTTGGCTG GGCGTGGTGG CTCACGCCTG TAATCCTGGC 480
ACTTTGGGAG GCCGAGGTGG GAGGACTGCT TAAAACCAGA AGTTTGAGAC CAGCCTGGGC 540
AACATAGCAA AACCCTGTTT CTTTTCTTTT TTTTTTTAAT GTTTTCTTAT CCCAGCTACA 600
TAGGTCTAAC ATTTCCGTCT CATCAACCCA ATCTCATTCT CCCTCCCAAA TAGTGTCAAC 660
AAAAACCACA GAACTTAAAA ACCATGTTTG CACTAGAAGA GACCTTCAAG ATCACCCGGT 720
GATCTCCTTA TTCACATAAG ACAAGCTCAG AGAGGGGAAG TGATATATCC AAGATCACTG 780
AAGAGACCAG ATAACCTACT TCCCTATCTC ATACAGTTGT TCATTTGTGT TCTGTGAGCT 840
AACCCTAGAA GCAGGATTTG ATGGTAGACT TGAACAACAC TCTGTCATAC CACCTTAAAA 900
ATCACCACAT AATTGCTGGG TGAGTAGACA GCCACTTAAA TAACCCATTT GATGTTATAC 960
TGATTCTAAC ACTATGATTT TAAAAGAGAA AGGAATACTT CATCTTCTGA GGAAGTCTCT 1020
ATGATCTAAA ATTAACTTTT TTCAAGGAAA TTCTCATCAT TGGTGAGCGA GCCACCTAGA 1080
GCTGACCTTT CAAAAATGCT GTGGAGCTCA CAGCAAACCA CCACGCAGAA TTTGCTGTTG 1140
ATTGCTCTTT TCACTCCTCC TCTCTGAAAC TAGCAAGAAC AGGAAGAAAT ATGTTTGTTC 1200
CCAGAGGTAC ATACAGTACT CAACTACAGG TACCACCTCT CTAGACTCAT TTTATAACTC 1260
AGCTGCTTAA TGCCATATTT ATCAGTCTTT TAAAAACCAT ATCTTCTTTG ATAAATATGA 1320
AAATCTCACG TCTTCTCCAC ACTCCGACCT CTTAAGTCTA TAATGTGCCT CTTTAGAGGG 1380
TATACAGCCA ATCCCCATCT TCTTTGAGGT TCTCTCCTTT TCTGGCTGGA CCTGGAGCCA 1440
ATCTATGCAT TTTCAAATTA TATATTCCCT TCCTATTTGT GACCTGTCTG CATGCTCACT 1500
ACCCCAAATA CAAGTTAAAA ATCACTGTCC TAATTTACTG CAGGCCAATG CCAATCATCA 1560
ACTAGAAAAT GAATGTATGC TTTGCTTAAA GATGAATTTC AGTAATATCT GAGTTTTTGA 1620
CACATGAGCT AATTGTCTCC ATCTTTACAG TATAGCATTT AAATGGTTTA GAGTTCCTTT 1680
ATATAGCTAA GATACACCCT ATATCTCTAC TTTTGAGATC AATGGTACCA GACGCCAATA 1740
ATTTAATCCA ATCAATAGAG ATTCACATGG CTTTCTGAAA GATGTTCTAC TTTGCTTTGG 1800
ATTTTGTTAT TTCTCAACTT TACTGAAACT CTATAAGATT CAATAGTTCT TATTGTAATA 1860
AGCGAGGTGA AGTCCTCAAA CACAGATCTA TTATACGATT GGAATAGGGA TAAATAAGGG 1920
AGGTTTGTAT ATCTCAAATC CGTCTAGTCT CTCCTGCCTG CCCAGCAAGT TTTAATTAGT 1980
ACTGATTTAC TGTAATATTC ATCCAGTTAA TTCATTCTCC AGTACCCACT 2030
|
